Infected mice were euthanized and the whole lungs were removed, resuspended in 2 ml of 1× PBS containing protease inhibitors (Complete Ultra tablets, Roche), and homogenized using a Precellys 24 homogenizer (Bertin Technologies). Samples were centrifuged to remove tissue debris and supernatants were transferred to a new tube. Viral titers were determined by plaque assay in MDCK cells followed by immunostaining. For the plaque assays, MDCK cells were seeded on 6-well plates 12 to 18 h prior to the assay. The virus suspensions were serially diluted in 1× PBS and 1 ml of the virus dilution was used to infect each well of MDCK cells for 1 h at 37°C. After the incubation, the virus was removed, the cells washed twice with 1× PBS and 3 ml of Avicell mix (1.2% Avicell in 1× MEM with bovine serum albumin [BSA] and trypsin) was added to each well. Plates were incubated at 37°C for 48 h (influenza A viruses) or at 34°C for 72 h (influenza B virus). After incubation, cells were fixed with 3 ml of 4% paraformaldehyde (PFA). For the immunostaining, the cells were blocked for 20 min with 5% milk in 1× PBS and the primary (test antibodies) and secondary antibody (anti-human IgG-HRP) were added sequentially. After the final wash, 500 μl of TrueBlue was added to visualize and count the plaques.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.